Proxalutamide (GT0918) is a Potent Androgen Receptor (AR) Antagonist
Androgen receptors (ARs) mediate cell differentiation and development of prostate cancer. The target is a common therapeutic target in prostate cancer. Proxalutamide (GT0918) design is based on the core structure…